Clorox vs Coty
CLX and COTY side by side, both in soap, detergents, and cleaning preparations; perfumes, cosmetics, and other toilet preparations. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CLX and COTY compare
Clorox is the larger company, worth 3.6 times as much as Coty ($12.9B against $3.6B).
Clorox grew revenue faster over the last twelve months (6.3% versus −0.24% for Coty).
Clorox keeps more of each dollar of sales as profit, with a net margin of 9.4% compared with −9.7% at Coty.
Clorox pays a dividend yielding 3.5%; Coty does not pay one.
Clorox scores higher on the StockData Score (14 against 3 for Coty), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CLX | COTY |
|---|---|---|
| Size and price | ||
| Market cap | $12.9B | $3.6B |
| Share price | $106.86 | $4.06 |
| Change, 1 year | 2.1% | 14.4% |
| Change, 5 years | −36.0% | −60.8% |
| Beta (5Y) | 0.50 | 1.00 |
| Employees | 9,200 | 11K |
| StockData Score | ||
| Total score | 14 (better) | 3 |
| Valuation score | 6 (better) | 1 |
| Growth score | 3 (better) | 0 |
| Performance score | 2 (better) | 0 |
| Health score | 0 | 2 (better) |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 19.2× | – |
| P/S | 1.8× | 0.6× (better) |
| P/B | – | 1.2× |
| EV/EBITDA | 13.7× (better) | 16.6× |
| P/FCF | 28.5× | 8.5× (better) |
| PEG | 0.33 | – |
| FCF yield | 3.5% | 11.8% (better) |
| Fair value | $197.34 | $3.70 |
| Margin of safety | 45.8% (better) | −9.7% |
| Growth | ||
| Revenue growth (TTM) | 6.3% (better) | −0.24% |
| Revenue growth, 5Y average | −1.8% | 4.6% (better) |
| Net income growth (TTM) | −14.4% | – |
| EPS growth (TTM) | −12.7% | – |
| EPS growth, 5Y average | −2.9% | – |
| Profitability | ||
| Gross margin | 41.9% | 62.6% (better) |
| Operating margin | – | −1.7% |
| Net margin | 9.4% (better) | −9.7% |
| FCF margin | 6.3% | 7.3% (better) |
| Return on equity | – | −16.7% |
| Return on invested capital | – | −1.2% |
| Financial health | ||
| Debt / equity | – | 0.89 |
| Net debt / EBITDA | 3.78 (better) | 6.71 |
| Interest coverage | – | −0.6× |
| Current ratio | 0.65 | 0.75 (better) |
| Altman Z-score | 1.81 (better) | −0.02 |
| Piotroski F-score | 3 | 3 |
| Dividends and buybacks | ||
| Dividend yield | 3.5% | – |
| Payout ratio | 88.9% | – |
| Years of dividend growth | 17 | – |
| Dividend growth, 5Y average | 2.2% | – |
| Buyback yield | 0.98% | – |
| Shareholder yield | 4.5% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 86.3% | 44.1% |
| Held by insiders | 0.68% | 61.5% |
| Insider net buying, 12 months | $829K (better) | $213K |
| Superinvestors holding | 2 (better) | 1 |
| Short interest, % of float | 9.0% | 11.7% |
Go deeper
- CLX stock overview
- CLX income statement
- CLX valuation and score
- COTY stock overview
- COTY income statement
- COTY valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.